BBVA USA’s Encompass Health EHC Stock Holding History

BBVA USA’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$62K	Buy	1,036 +91	+10%	+$5.73K	﹤0.01%	619
2021 Q2	$59K	Buy	+945	New	+$63K	﹤0.01%	641

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BBVA USA's EHC Position: Q3 2021 in Review

BBVA USA increased its Encompass Health (EHC) stake by 9.6% in Q3 2021, buying an estimated $5.73K and bringing the position to 1,036 shares worth $62K. The position accounts for ﹤0.01% of the portfolio, ranked #619.

BBVA USA first reported a position in EHC in Q2 2021 and has held it in 2 quarters since. 435 funds tracked by Wall St. Rank hold EHC as of Q3 2021.

BBVA USA held 1,036 shares of Encompass Health worth $62K as of Q3 2021.
BBVA USA bought 91 Encompass Health shares in Q3 2021, an estimated $5.73K.
Encompass Health made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #619 holding.
BBVA USA first reported a position in Encompass Health in Q2 2021 and has held it in 2 quarters since.
435 funds tracked by Wall St. Rank held Encompass Health as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.